Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin for venous thromboembolic disease
ChiCTR-TRC-14005223Phase 4Recruiting
- Sponsor
- State Key Laboratory of Respiratory Disease
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous thromboembolism (VTE), pulmonary embolism (PE) and deep vein thrombosis (DVT) comparing Warfarin group with Rivaroxaban group (2 arms). Primary endpoints: Computed Tomography Pulmonary Angiography, Bleeding events and 2 more. Started Sep 2014; status: recruiting.
02
Drugs
rivaroxabanwarfarin
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR-TRC-14005223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005223.